April 2011
Volume 52, Issue 14
ARVO Annual Meeting Abstract  |   April 2011
Proton Radiation Destroys VEGF Enriched Choroidal Endothelial Cell Proliferation, an association With Age Related Macular Degeneration
Author Affiliations & Notes
  • KV Chalam
    Univ of Florida-Jacksonville, Jacksonville, Florida
  • S Balaiya
    Univ of Florida-Jacksonville, Jacksonville, Florida
  • R Malyapa
    Radiation Oncology,
    Univ of Florida-Jacksonville, Jacksonville, Florida
  • Footnotes
    Commercial Relationships  KV Chalam, None; S. Balaiya, None; R. Malyapa, None
  • Footnotes
    Support  None
Investigative Ophthalmology & Visual Science April 2011, Vol.52, 1780. doi:
  • Views
  • Share
  • Tools
    • Alerts
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      KV Chalam, S Balaiya, R Malyapa; Proton Radiation Destroys VEGF Enriched Choroidal Endothelial Cell Proliferation, an association With Age Related Macular Degeneration. Invest. Ophthalmol. Vis. Sci. 2011;52(14):1780.

      Download citation file:

      © ARVO (1962-2015); The Authors (2016-present)

  • Supplements

Purpose: : Exudative form of age related macular degeneration (AMD) is the leading cause of blindness above the age of 65 in the western world. Choridcal neovasculization (CNV) is characterized by vascular endothelial growth factor (VEGF) mediated choroidal endothelial cell (CEC) proliferation. CNV is currently being treated with ant-VEGF therapy but requires repeated intravitreal injections. Novel treatments such as proton beam radiation delivers a homogenous three-dimensional dose to the target lesion with minimal damage to surrounding healthy tissues and may reduce the frequency of repeat intravitreal treatments. We evaluated the sensitivity of proliferating CEC enriched with VEGF to escalating doses of proton beam radiation to optimize effective dose level.

Methods: : Choridal endothelial cells were maintained at log-scale enriched with VEGF at a concentration of 50ng/mL. Semi-confluent cells were exposed to single fraction of varying radiation dose. Dosage ranged from 2, 4, 8 and 12 CGE (Cobalt Gray Equivalent) with a presence of an internal control. Post radiation viability of choroidal endothelial cells were analyzed on day 2 and day 5 using WST-1 assay. Cell survival was quantified with trypan blue dye exclusion assay using Vi-cell XR.

Results: : On day 2, WST-1 assay results showed 98.1% of viability at 2 CGE, 96.1% at 4CGE, 83.4% at 8 CGE and 68.9% at 12 CGE, compared to control. However, on day 5, the viability decreased to 58.2%, 57.6%, 51.6% and 27% at 2, 4, 8 and 12 CGE respecively after radiation. Vi-cell XR studies confirmed the number of viable cells as 97.9%, 72.6%, 57.5%, 47.2% at 2, 4, 8 and 12 CGE of post radiation day 2. The cell numbers decreased at further day interval 5 which were of 68.4%, 58.9%, 31.5% and 25.3% proportionate to the degree of radiation.( r=0.7)

Conclusions: : Proton beam radiation at doses of 8 and 12 CGE significantly decreases cell viability of VEGF induced choroidal endothelial cells and can be used as starting treatment dose for choroidal neovascularization associate with age related macular degeneration.

Keywords: age-related macular degeneration • choroid: neovascularization • radiation therapy 

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.